Xiaoyang Zhou to Disease-Free Survival
This is a "connection" page, showing publications Xiaoyang Zhou has written about Disease-Free Survival.
Connection Strength
0.037
-
Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: An exploratory clinical trial. Clin Transl Med. 2021 02; 11(2):e297.
Score: 0.037